Taken together, these results provide an innovative molecular basis of GTEE in PCa cells, and targeting the SREBP-1/AR axis by GTEE could be a promising approach for the treatment of malignant PCa. The gene discussed is SREBF1; the disease is posterior cortical atrophy.